XML 61 R52.htm IDEA: XBRL DOCUMENT
v3.23.3

SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares shares in Thousands | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Number of stock options, options outstanding, exercised, shares | [1] |  |  |  |  | (8) |
Number of stock options, options outstanding, forfeited, shares |  |  |  | (48) |  | (9) |
Consultants For Services [Member] |  |  |  |  |  |  |
Grants of warrants |  | 86 | [2] | 42 | [3] | 15 | [4]
Number of stock options, options outstanding, exercised, shares | [5] | (187) |  |  |  |  |
Number of stock options, options outstanding, forfeited, shares |  | (2) |  |  |  |  |
Warrant price, grants | [6] |  |  | $ 26.25 |  | $ 189.00 |
Private Placement [Member] |  |  |  |  |  |  |
Grants of warrants | [7] | 453 |  |  |  |  |
Acquisition Of Assets [Member] |  |  |  |  |  |  |
Grants of warrants | [8] |  |  |  |  | 9 |
Warrant price, grants |  |  |  |  |  | $ 189.00 |
Warrant [Member] |  |  |  |  |  |  |
Warrants outstanding, beginning balance |  | 145 | [4] | 102 |  | 78 |
Warrant price, beginning balance | [6] | $ 136.8 |  | $ 186.00 |  | $ 109.50 |
Weighted average remaining contractual life, beginning | [9] | 2 years 6 months |  |  |  |  |
Warrants outstanding, ending balance |  | 496 | [10] | 145 | [4] | 102 |
Warrant price, beginning balance |  | $ 59.5 | [11] | $ 136.8 | [6] | $ 186.00 | [6]
Weighted average remaining contractual life, beginning | [9] | 5 years 8 months 12 days |  | 2 years 6 months |  |  |
Warrants outstanding, exercisable ending balance |  | 429 | [12] | 124 | [8] | 92 |
Warrant price, exercisable ending balance |  | $ 62.2 | [11] | $ 145.00 | [6] | $ 185.50 | [6]
Weighted average remaining contractual life, exercisable ending |  | 3 years 10 months 24 days | [9] | 2 years 6 months | [13] | 3 years 1 month 6 days | [13]
Weighted average remaining contractual life, beginning | [13] | 2 years 7 months 6 days |  | 3 years 1 month 6 days |  | 4 years 2 months 12 days |
Weighted average remaining contractual life, ending | [13] |  |  | 2 years 7 months 6 days |  | 3 years 1 month 6 days |
[1] | On the respective exercise dates as of December 31, 2021, the aggregate intrinsic value of shares of Common Stock issued upon exercise of stock options amounted to $0.6 million.
[2] | In February 2023, the Company granted warrants to consultants in exchange for business development, product development and distribution. Warrants issued in February 2023 provide for the purchase of an aggregate of 84,000 shares of common stock at an exercise price of $22.75 and $15.25 per share with a fair value of approximately $1.3 million which will be recognized upon the achievement of performance metrics and milestones. In June 2023, the Company granted warrants to consultants in exchange for services. Warrants issued in June 2023 provide for the purchase of an aggregate of 1,500 shares of common stock at an exercise price of $10.25 per share at a fair value of approximately $0.1 million which will be recognized upon the achievement of performance metrics and milestones. In August 2023, the Company granted warrants to consultants in exchange for services. Warrants issued in August 2023 provide for the purchase of an aggregate of 900 shares of common stock at an exercise price of $8.50 per share at a fair value of approximately less than $0.1 million which will be recognized per the vesting schedule. For the nine months ended September 30, 2023, the Company recognized expense of $0.7 million.
[3] | In February, 2022, the Company granted warrants to consultants in exchange for marketing, business development, investor relations and communication services. Warrants issued in February 2022 provide for the purchase of an aggregate of 3,200 shares of Common Stock and are exercisable at $81.75 per share. The aggregate fair value of the February warrants amounted to $0.1 million, which is being recognized over the period that the services are provided. In May, 2022, the Company granted warrants to consultants in exchange for marketing and business development services. Warrants issued in May 2022 provide for the purchase of an aggregate of 5,200 shares of Common Stock and are exercisable at $32.25 per share. The aggregate fair value of the May warrants amounted to $0.1 million, which is being recognized over the period that the services are provided. Warrants issued in December 2022 provide for the purchase of an aggregate of 34,000 shares of Common Stock and are exercisable at $12.00 per share. The aggregate fair value of the December warrants amounted to $0.2 million, which is being recognized over the period that the services are provided or according to the vesting schedule. For the year ended December 31, 2022, the Company recognized expense of $0.7 million.
[4] | As of December 31, 2022 and 2021, the aggregate intrinsic value of warrants outstanding was $0.
[5] | In March 2023, the Company issued an aggregate of 186,667 shares of common stock from the exercise of warrants previously issued in January 2023.
[6] | Represents the weighted average exercise price.
[7] | In January 2023, the Company granted warrants in connection with a private placement consisting of pre-funded warrants to purchase up to an aggregate of 186,667 shares of common stock at an exercise price of $0.0001 per share, and warrants to purchase up to an aggregate of 266,667 shares of common stock at an exercise price of $30 per share with a fair value of approximately $14.5 million which was recognized as warrant liability at the time of issuance.
[8] | As of December 31, 2022 and 2021, the aggregate intrinsic value of warrants exercisable was $0.
[9] | Represents the weighted average remaining contractual term until the warrants expire.
[10] | As of September 30, 2023, the aggregate intrinsic value of warrants outstanding was $0.
[11] | Represents the weighted average exercise price.
[12] | As of September 30, 2023, the aggregate intrinsic value of warrants exercisable was $0.
[13] | Represents the weighted average remaining contractual term until the warrants expire.

X
- Definition Warrant exercisable per shares. + References No definition available. + Details
Name: | VVOS_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable
Namespace Prefix: | VVOS_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrants or rights exercisable, shares. + References No definition available. + Details
Name: | VVOS_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercisable
Namespace Prefix: | VVOS_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Share based compensation arrangement by share based payment award options equity instruments exercise in price grants in period. + References No definition available. + Details
Name: | VVOS_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExerciseInPriceGrantsInPeriod
Namespace Prefix: | VVOS_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants and rights outstanding exercisable term. + References No definition available. + Details
Name: | VVOS_WarrantsAndRightsOutstandingExercisableTerm
Namespace Prefix: | VVOS_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants and rights outstanding years. + References No definition available. + Details
Name: | VVOS_WarrantsAndRightsOutstandingYears
Namespace Prefix: | VVOS_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_AwardTypeAxis=VVOS_ConsultantsForServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=VVOS_AcquisitionOfAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |